chr10-59234378-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_032439.4(PHYHIPL):āc.181A>Gā(p.Ile61Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000187 in 1,603,560 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_032439.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PHYHIPL | NM_032439.4 | c.181A>G | p.Ile61Val | missense_variant | 2/5 | ENST00000373880.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PHYHIPL | ENST00000373880.9 | c.181A>G | p.Ile61Val | missense_variant | 2/5 | 1 | NM_032439.4 | P1 | |
PHYHIPL | ENST00000373878.3 | c.103A>G | p.Ile35Val | missense_variant | 2/5 | 1 | |||
PHYHIPL | ENST00000486074.2 | c.*122A>G | 3_prime_UTR_variant, NMD_transcript_variant | 3/6 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00000659 AC: 1AN: 151838Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000414 AC: 1AN: 241520Hom.: 0 AF XY: 0.00000762 AC XY: 1AN XY: 131202
GnomAD4 exome AF: 0.0000200 AC: 29AN: 1451722Hom.: 1 Cov.: 30 AF XY: 0.0000194 AC XY: 14AN XY: 722406
GnomAD4 genome AF: 0.00000659 AC: 1AN: 151838Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74150
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 11, 2024 | The c.181A>G (p.I61V) alteration is located in exon 2 (coding exon 2) of the PHYHIPL gene. This alteration results from a A to G substitution at nucleotide position 181, causing the isoleucine (I) at amino acid position 61 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at